Biotechnology News avian flu Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-25 out of 471 found

Current Search: avian: 471, flu: 1301

Biota Holdings Limited (ASX:BTA) Quarterly Royalties from Relenza
Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received written notification from GlaxoSmithKline (LON:GSK)(PINK:GLAXF) that indicative royalties from Relenza were $0.4m during the three months ended 30 June 2008,...

ITnews: Jul 24 2008 12:40PM
Matching: avian flu

Find similar documents

Rockeby receives bird flu test orders
Singapore based healthcare company Rockeby Biomed has received orders for its bird flu test worth $230,000 from several countries in Asia, Africa and Europe.

Rockeby is listed in Australian stock exchange.

Rockeby Chief Executive...

Bio Spectrum Asia: Jul 24 2008 5:42AM
Matching: avian flu

Find similar documents

Cancer Treatment Application of the Aethlon Hemopurifier(R) Published in Journal of Translational Medicine
Author : CA-AETHLON-MEDICAL Category : Press Release News Alerts by Email ( click here ) Press Release News | Home SAN DIEGO - (Business Wire) Aethlon Medical, Inc.

(OTCBB:AEMD) disclosed today that a peer reviewed scientific paper...

Earthtimes.org: Jul 24 2008 11:29AM
Matching: avian flu

Find similar documents

Cancer Treatment Application of the Aethlon Hemopurifier(R) Published in Journal of Translational Medicine
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc.

(OTCBB:AEMD - News) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine.

The paper entitled...

Yahoo! Canada: Jul 24 2008 11:29AM
Matching: avian flu

Find similar documents

Emergence of H1N1 Relenza Resistance in New Jersey? (07/22/08 20:25)
The recent explosion of oseltamivir (Tamiflu) resistance in H1N1 has focused attention on the emergence of resistance against all approved anti-virals.

H5N1 clade 1 had two resistance markers for the amantadines, which included M2 S31N.

Recombinonics: Jul 24 2008 11:29AM
Matching: avian flu

Find similar documents

Emergent BioSolutions and the University of Oxford form joint venture to develop an advanced Tuberculosis vacc
Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan drug...

Checkbiotech: Jul 23 2008 1:57PM
Matching: avian flu

Find similar documents

Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
- The University of Oxford and Emergent BioSolutions Inc.

(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.

(the 'Consortium'), to further develop MVA85A, the world's most...

Pharmalive.com: Jul 23 2008 1:16PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
Study Demonstrates Feasibility and Efficacy of Treating Patients with Primary Liver Cancer SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean...

KOTA Territory News: Jul 23 2008 7:47AM
Matching: avian flu

Find similar documents

Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
The University of Oxford and Emergent BioSolutions Inc.

(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.

(the 'Consortium'), to further develop MVA85A, the world's most...

Genetic Engineering News: Jul 23 2008 4:38AM
Matching: avian flu

Find similar documents

Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
-- Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan drug...

Yahoo!: Jul 23 2008 4:19AM
Matching: avian flu

Find similar documents

Canadian Bio Med Systems Ltd., a wholly owned subsidiary of ICBS, announces the company has signed a prelimina
NEW YORK, NY, MONTREAL and SAN DIEGO, CA, July 22 /PRNewswire-FirstCall/ - Canadian Bio Med Systems Inc., a wholly owned subsidiary of ICBS Limited (ICBS) is pleased to announce that it has signed a preliminary agreement for the licensing...

KOTA Territory News: Jul 23 2008 7:47AM
Matching: avian

Find similar documents

Canadian Bio Med Systems Ltd., a Wholly Owned Subsidiary of ICBS, Announces the Company Has Signed a Prelimina
/PRNewswire-FirstCall/ - Canadian Bio Med Systems Inc., a wholly owned subsidiary of ICBS Limited (ICBS) is pleased to announce that it has signed a preliminary agreement for the licensing rights to two new potentially revolutionary drugs in...

Pharmalive.com: Jul 23 2008 1:09AM
Matching: avian

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

Financials.com: Jul 22 2008 10:19PM
Matching: avian flu

Find similar documents

(San Francisco, CA and Ottawa, Ontario), and its South Korean...

KRON4: Jul 22 2008 9:09PM
Matching: avian flu

Find similar documents

(San Francisco, CA and Ottawa, Ontario), and its South...

Pharmalive.com: Jul 22 2008 7:55PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

Atlanta Business Chronicle: Jul 22 2008 1:57PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

The Business Journal Phoenix: Jul 22 2008 1:52PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

Columbus Business First: Jul 22 2008 1:52PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

Cincinnati Business Journal: Jul 22 2008 1:50PM
Matching: avian flu

Find similar documents

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer an
SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc.

(San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announced today that novel findings from a Phase I clinical trial of...

Portland Business Journal: Jul 22 2008 1:48PM
Matching: avian flu

Find similar documents

KRON4: Jul 22 2008 9:08PM
Matching: avian

Find similar documents

IETV1/I rearrangements heterogeneous in prostate cancer
MedWire News: There is a great degree of heterogeneity of Ets variant gene 1 (ETV1) rearrangements in prostate cancer, says an international team of researchers in findings that identified a novel fusion partner for the gene.

Although...

MedWire News: Jul 22 2008 3:14PM
Matching: avian

Find similar documents

Biota Holdings Limited (ASX:BTA) and GSK conclude Litigation through Mediation
Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced it had concluded its litigation against GlaxoSmithKline (GSK).

The announcement followed formal mediation between by the parties ordered by the Victorian Supreme Court.

The...

ITnews: Jul 22 2008 12:17PM
Matching: avian

Find similar documents

Biota Holdings Limited (ASX:BTA) and GSK Conclude Litigation Through Mediation
- (ABN Newswire<http://www.abnnewswire.

%20com/en>) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced it had concluded its litigation against GlaxoSmithKline (GSK).

The announcement followed formal mediation...

Drugs.com: Jul 22 2008 2:29AM
Matching: avian

Find similar documents

Glaxosmithkline to pay Australia's Biota Holdings $20 mln as litigation settlement - Update
(RTTNews) - Australia's Biota Holdings Ltd.

(BTAHY.PK: News, Chart, Quote ) said Sunday that it has reached a settlement with GlaxosmithKline plc.

(GSK: News, Chart, Quote , GSK.L) related to the litigation against GlaxosmithKline.

The...

RTTNews.com: Jul 21 2008 3:53AM
Matching: avian flu

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.